Drugs / RO7058584
last change Dec 2017 re-read 9 days ago

RO7058584

Developed for
ocular hypertension · open-angle glaucoma
Investigated by
Hoffmann-La Roche

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03293992 Oct → Dec 2017 ocular hypertension, open-angle glaucoma Hoffmann-La Roche Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RO7058584 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03293992 ↗
Route Topical “Topical Instillation of Eye Drops” NCT03293992 ↗